- Release Date: 06/09/24 09:10
- Summary: Cleo Commences U.S. Clinical Trials
- Price Sensitive: Yes
- Download Document 526.04KB
- Forums
- ASX - By Stock
- COV
- Ann: Cleo Commences U.S. Clinical Trials
Ann: Cleo Commences U.S. Clinical Trials
Featured News
Add COV (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $30.19M |
Open | High | Low | Value | Volume |
38.0¢ | 38.0¢ | 37.0¢ | $11.85K | 31.91K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 44994 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 380 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 44994 | 0.365 |
3 | 15535 | 0.360 |
2 | 10562 | 0.355 |
3 | 19251 | 0.350 |
2 | 23187 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 380 | 1 |
0.385 | 6027 | 2 |
0.390 | 9554 | 1 |
0.395 | 95179 | 3 |
0.400 | 9000 | 1 |
Last trade - 13.37pm 12/11/2024 (20 minute delay) ? |
Featured News
COV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online